Michael S. Kiernan

6.4k total citations · 4 hit papers
103 papers, 3.8k citations indexed

About

Michael S. Kiernan is a scholar working on Biomedical Engineering, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael S. Kiernan has authored 103 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Biomedical Engineering, 62 papers in Surgery and 57 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael S. Kiernan's work include Mechanical Circulatory Support Devices (68 papers), Cardiac Structural Anomalies and Repair (56 papers) and Heart Failure Treatment and Management (42 papers). Michael S. Kiernan is often cited by papers focused on Mechanical Circulatory Support Devices (68 papers), Cardiac Structural Anomalies and Repair (56 papers) and Heart Failure Treatment and Management (42 papers). Michael S. Kiernan collaborates with scholars based in United States, France and Japan. Michael S. Kiernan's co-authors include Navin K. Kapur, Duc Thinh Pham, Francis D. Pagani, David DeNofrio, Biykem Bozkurt, Kevin Morine, G. Michael Felker, Robb D. Kociol, Marvin A. Konstam and Miriam Jacob and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Michael S. Kiernan

96 papers receiving 3.7k citations

Hit Papers

Evaluation and Management of Right-Sided Heart Failure: A... 2016 2026 2019 2022 2018 2016 2017 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Kiernan United States 28 2.0k 1.9k 1.9k 973 642 103 3.8k
Teruhiko Imamura Japan 26 1.4k 0.7× 1.4k 0.7× 1.3k 0.7× 653 0.7× 735 1.1× 430 3.1k
Chiara Lazzeri Italy 29 1.1k 0.6× 1.8k 0.9× 737 0.4× 654 0.7× 669 1.0× 205 3.5k
Tomoko S. Kato Japan 29 1.4k 0.7× 1.6k 0.8× 959 0.5× 403 0.4× 277 0.4× 98 3.1k
Massimo Massetti Italy 31 1.7k 0.8× 2.2k 1.1× 733 0.4× 748 0.8× 1.4k 2.2× 283 4.3k
Young Bin Song South Korea 36 2.7k 1.3× 2.6k 1.4× 796 0.4× 712 0.7× 612 1.0× 253 4.3k
Kenshi Fujii Japan 35 2.2k 1.1× 4.5k 2.3× 728 0.4× 475 0.5× 316 0.5× 170 5.8k
John N. Nanas Greece 31 963 0.5× 1.8k 1.0× 1.1k 0.6× 565 0.6× 276 0.4× 142 3.0k
Keyur B. Shah United States 26 1.2k 0.6× 1.3k 0.7× 977 0.5× 457 0.5× 228 0.4× 153 2.6k
Joseph C. Cleveland United States 28 2.1k 1.0× 1.7k 0.9× 1.5k 0.8× 750 0.8× 397 0.6× 86 3.5k
Akira Sezai Japan 31 1.2k 0.6× 1.6k 0.8× 528 0.3× 367 0.4× 825 1.3× 200 2.8k

Countries citing papers authored by Michael S. Kiernan

Since Specialization
Citations

This map shows the geographic impact of Michael S. Kiernan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Kiernan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Kiernan more than expected).

Fields of papers citing papers by Michael S. Kiernan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Kiernan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Kiernan. The network helps show where Michael S. Kiernan may publish in the future.

Co-authorship network of co-authors of Michael S. Kiernan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Kiernan. A scholar is included among the top collaborators of Michael S. Kiernan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Kiernan. Michael S. Kiernan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tuttle, Marcelle, Hocine Tighiouart, Jeffrey M. Testani, et al.. (2025). Novel Hemodynamic Markers and Kidney Function in Patients with Acute Decompensated Heart Failure. Kidney360. 6(5). 728–738.
2.
Zalawadiya, Sandip, Michael S. Kiernan, Barry A. Borlaug, et al.. (2025). Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring. Journal of Cardiac Failure. 32(1). 32–42. 2 indexed citations
4.
Grady, Kathleen L., Michael A. Kallen, David G. Beiser, et al.. (2023). Novel measures to assess ventricular assist device patient-reported outcomes: Findings from the MCS A-QOL study. The Journal of Heart and Lung Transplantation. 43(1). 36–50. 3 indexed citations
5.
Vest, Amanda R., Lori Lyn Price, Benjamin Sweigart, et al.. (2023). Cardiac Cachexia in Left Ventricular Assist Device Recipients and the Implications of Weight Gain Early After Implantation. Journal of the American Heart Association. 12(13). e029086–e029086. 10 indexed citations
6.
Gulati, Gaurav, E. Wilson Grandin, David DeNofrio, et al.. (2022). Association between postoperative hemodynamic metrics of pulmonary hypertension and right ventricular dysfunction and clinical outcomes after left ventricular assist device implantation. The Journal of Heart and Lung Transplantation. 41(10). 1459–1469. 9 indexed citations
7.
Kennedy, Kevin F., Marwa Sabe, Jennifer E. Ho, et al.. (2022). Abstract 12180: Post-Implant Beta Blocker Use and Late Right Heart Failure After LVAD Implantation: An STS-INTERMACS Analysis. Circulation. 146(Suppl_1).
8.
Allen, Steven R., Mark S. Slaughter, Mustafa M. Ahmed, et al.. (2022). COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device. The Journal of Heart and Lung Transplantation. 42(1). 33–39. 17 indexed citations
9.
Grandin, E. Wilson, Gaurav Gulati, Jose I. Nunez, et al.. (2022). Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis. Circulation Heart Failure. 15(4). e008613–e008613. 5 indexed citations
10.
Brinkley, D. Marshall, Li Wang, Chang Yu, E. Wilson Grandin, & Michael S. Kiernan. (2021). Impact of renin-angiotensin-aldosterone system inhibition on morbidity and mortality during long-term continuous-flow left ventricular assist device support: An IMACS report. The Journal of Heart and Lung Transplantation. 40(12). 1605–1613. 9 indexed citations
11.
Shah, Palak, Richard Ha, Ramesh Singh, et al.. (2018). Multicenter experience with durable biventricular assist devices. The Journal of Heart and Lung Transplantation. 37(9). 1093–1101. 38 indexed citations
12.
Kiernan, Michael S., Susanna R. Stevens, W.H. Wilson Tang, et al.. (2018). Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials. Journal of Cardiac Failure. 24(7). 428–438. 32 indexed citations
13.
Breeze, Janis L., Stanton K. Shernan, Navin K. Kapur, et al.. (2018). Intraoperative Hemodynamic and Echocardiographic Measurements Associated With Severe Right Ventricular Failure After Left Ventricular Assist Device Implantation. Anesthesia & Analgesia. 128(1). 25–32. 27 indexed citations
14.
Chow, Sheryl L., Alan S. Maisel, Inder S. Anand, et al.. (2017). Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 135(22). e1054–e1091. 404 indexed citations breakdown →
15.
Kiernan, Michael S., Kartik S. Sundareswaran, Duc Thinh Pham, et al.. (2016). Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy. Journal of Cardiac Failure. 22(10). 797–805. 28 indexed citations
16.
Breeze, Janis L., et al.. (2016). Left Ventricular Assist Device Thrombosis Is Associated With an Increase in the Systolic-to-Diastolic Velocity Ratio Measured at the Inflow and Outflow Cannulae. Journal of Cardiothoracic and Vascular Anesthesia. 31(2). 497–504. 7 indexed citations
17.
Grodin, Justin L., Susanna R. Stevens, Lisa de las Fuentes, et al.. (2015). Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure. Journal of Cardiac Failure. 22(1). 26–32. 41 indexed citations
18.
Urbano-Moral, José Ángel, José Antonio Arias‐Godínez, H. R. Ahmad, et al.. (2013). Evaluation of myocardial mechanics with three-dimensional speckle tracking echocardiography in heart transplant recipients: comparison with two-dimensional speckle tracking and relationship with clinical variables. European Heart Journal - Cardiovascular Imaging. 14(12). 1167–1173. 36 indexed citations
19.
Kiernan, Michael S., Deborah Wentworth, Gary S. Francis, et al.. (2012). Predicting Adverse Events During Angiotensin Receptor Blocker Treatment in Heart Failure: Results from the HEAAL Trial. European Journal of Heart Failure. 14(12). 1401–1409. 25 indexed citations
20.
Kiernan, Michael S., Duc Thinh Pham, David DeNofrio, & Navin K. Kapur. (2011). Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics. Journal of Thoracic and Cardiovascular Surgery. 142(3). 712–714. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026